Invasive therapies for patients with concomitant heart failure and atrial fibrillation
Atrial fibrillation (AF) and heart failure (HF) are two clinical entities that can present either separately or concurrently. One entity can lead to the other and vice versa as AF can not only be the underlying etiology of HF but also exacerbate HF due to other cardiac diseases. Besides prevention o...
Gespeichert in:
| Veröffentlicht in: | Heart failure reviews 2019-09, Vol.24 (5), p.821-829 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 829 |
|---|---|
| container_issue | 5 |
| container_start_page | 821 |
| container_title | Heart failure reviews |
| container_volume | 24 |
| creator | Wei, Wei Shehata, Michael Wang, Xunzhang Rao, Fang Zhan, Xianzhan Guo, Huiming Fang, Xianhong Liao, Hongtao Liu, Jian Deng, Hai Liu, Yang Xue, Yumei Wu, Shulin |
| description | Atrial fibrillation (AF) and heart failure (HF) are two clinical entities that can present either separately or concurrently. One entity can lead to the other and vice versa as AF can not only be the underlying etiology of HF but also exacerbate HF due to other cardiac diseases. Besides prevention of cerebral and systemic embolism and elimination of AF-related symptoms, restoration of sinus rhythm for AF patients helps to avoid or reduce HF, irrespective of their underlying heart disease. Successful rates of medical therapy for AF are low in persistent AF, and much lower in long-standing AF, while invasive procedures for AF yield promising results. In this review, the authors evaluate the value of invasive therapies for HF patients complicated with non-valvular AF. We examine this clinical problem by interpreting the relationships between these two entities: the mechanism of tachycardia-induced cardiomyopathy (TIC), past opinions about rhythm control and rate control of AF, discrimination of HF-related AF and AF-induced HF, how to identify the AF patients that could benefit from invasive therapies, and how to select invasive therapies for different AF patients and peri-operative treatments. |
| doi_str_mv | 10.1007/s10741-019-09795-0 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2229231329</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2218897954</sourcerecordid><originalsourceid>FETCH-LOGICAL-c375t-58155b78c4adc535af051f13fe6ebb1218127ab22230544dbbf6fc2d45e7de73</originalsourceid><addsrcrecordid>eNp9kMtKBDEQRYMovn_AhQTcuGlN5WG6lyK-QHAjbkO6u-JEetJjklb8ezOOD3DhKgU591ZxCDkAdgKM6dMETEuoGDQVa3SjKrZGtkFpUWnB-XqZRc0rCVJvkZ2UnhljspFsk2wJKJOWzTZ5vA2vNvlXpHmG0S48JurGSBc2eww50TefZ7QbQzfOfbYh0xnamKmzfpgiUht6anP0dqDOt9EPQwmOYY9sODsk3P96d8nD1eXDxU11d399e3F-V3VCq1ypGpRqdd1J23dKKOuYAgfC4Rm2LXCogWvbcs4FU1L2bevOXMd7qVD3qMUuOV7VLuL4MmHKZu5Th-WIgOOUTAk2XIDgTUGP_qDP4xRDOa5QUNdLgbJQfEV1cUwpojOL6Oc2vhtgZindrKSbIt18SjeshA6_qqd2jv1P5NtyAcQKSOUrPGH83f1P7Qe8lo09</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2218897954</pqid></control><display><type>article</type><title>Invasive therapies for patients with concomitant heart failure and atrial fibrillation</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Wei, Wei ; Shehata, Michael ; Wang, Xunzhang ; Rao, Fang ; Zhan, Xianzhan ; Guo, Huiming ; Fang, Xianhong ; Liao, Hongtao ; Liu, Jian ; Deng, Hai ; Liu, Yang ; Xue, Yumei ; Wu, Shulin</creator><creatorcontrib>Wei, Wei ; Shehata, Michael ; Wang, Xunzhang ; Rao, Fang ; Zhan, Xianzhan ; Guo, Huiming ; Fang, Xianhong ; Liao, Hongtao ; Liu, Jian ; Deng, Hai ; Liu, Yang ; Xue, Yumei ; Wu, Shulin</creatorcontrib><description>Atrial fibrillation (AF) and heart failure (HF) are two clinical entities that can present either separately or concurrently. One entity can lead to the other and vice versa as AF can not only be the underlying etiology of HF but also exacerbate HF due to other cardiac diseases. Besides prevention of cerebral and systemic embolism and elimination of AF-related symptoms, restoration of sinus rhythm for AF patients helps to avoid or reduce HF, irrespective of their underlying heart disease. Successful rates of medical therapy for AF are low in persistent AF, and much lower in long-standing AF, while invasive procedures for AF yield promising results. In this review, the authors evaluate the value of invasive therapies for HF patients complicated with non-valvular AF. We examine this clinical problem by interpreting the relationships between these two entities: the mechanism of tachycardia-induced cardiomyopathy (TIC), past opinions about rhythm control and rate control of AF, discrimination of HF-related AF and AF-induced HF, how to identify the AF patients that could benefit from invasive therapies, and how to select invasive therapies for different AF patients and peri-operative treatments.</description><identifier>ISSN: 1382-4147</identifier><identifier>EISSN: 1573-7322</identifier><identifier>DOI: 10.1007/s10741-019-09795-0</identifier><identifier>PMID: 31049749</identifier><language>eng</language><publisher>New York: Springer US</publisher><subject>Animals ; Atrial Fibrillation - physiopathology ; Atrial Fibrillation - surgery ; Cardiac arrhythmia ; Cardiology ; Cardiomyopathy ; Cardiomyopathy, Dilated - diagnosis ; Cardiomyopathy, Dilated - etiology ; Cardiomyopathy, Dilated - surgery ; Catheter Ablation - methods ; Congestive heart failure ; Coronary artery disease ; Embolism ; Etiology ; Fibrillation ; Heart failure ; Heart Failure - physiopathology ; Heart Failure - surgery ; Humans ; Medicine ; Medicine & Public Health ; Patients ; Prognosis ; Prostate ; Risk Factors ; Tachycardia ; Tachycardia - complications ; Treatment Outcome</subject><ispartof>Heart failure reviews, 2019-09, Vol.24 (5), p.821-829</ispartof><rights>Springer Science+Business Media, LLC, part of Springer Nature 2019</rights><rights>Heart Failure Reviews is a copyright of Springer, (2019). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c375t-58155b78c4adc535af051f13fe6ebb1218127ab22230544dbbf6fc2d45e7de73</citedby><cites>FETCH-LOGICAL-c375t-58155b78c4adc535af051f13fe6ebb1218127ab22230544dbbf6fc2d45e7de73</cites><orcidid>0000-0001-9721-3077</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10741-019-09795-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10741-019-09795-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31049749$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Shehata, Michael</creatorcontrib><creatorcontrib>Wang, Xunzhang</creatorcontrib><creatorcontrib>Rao, Fang</creatorcontrib><creatorcontrib>Zhan, Xianzhan</creatorcontrib><creatorcontrib>Guo, Huiming</creatorcontrib><creatorcontrib>Fang, Xianhong</creatorcontrib><creatorcontrib>Liao, Hongtao</creatorcontrib><creatorcontrib>Liu, Jian</creatorcontrib><creatorcontrib>Deng, Hai</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Xue, Yumei</creatorcontrib><creatorcontrib>Wu, Shulin</creatorcontrib><title>Invasive therapies for patients with concomitant heart failure and atrial fibrillation</title><title>Heart failure reviews</title><addtitle>Heart Fail Rev</addtitle><addtitle>Heart Fail Rev</addtitle><description>Atrial fibrillation (AF) and heart failure (HF) are two clinical entities that can present either separately or concurrently. One entity can lead to the other and vice versa as AF can not only be the underlying etiology of HF but also exacerbate HF due to other cardiac diseases. Besides prevention of cerebral and systemic embolism and elimination of AF-related symptoms, restoration of sinus rhythm for AF patients helps to avoid or reduce HF, irrespective of their underlying heart disease. Successful rates of medical therapy for AF are low in persistent AF, and much lower in long-standing AF, while invasive procedures for AF yield promising results. In this review, the authors evaluate the value of invasive therapies for HF patients complicated with non-valvular AF. We examine this clinical problem by interpreting the relationships between these two entities: the mechanism of tachycardia-induced cardiomyopathy (TIC), past opinions about rhythm control and rate control of AF, discrimination of HF-related AF and AF-induced HF, how to identify the AF patients that could benefit from invasive therapies, and how to select invasive therapies for different AF patients and peri-operative treatments.</description><subject>Animals</subject><subject>Atrial Fibrillation - physiopathology</subject><subject>Atrial Fibrillation - surgery</subject><subject>Cardiac arrhythmia</subject><subject>Cardiology</subject><subject>Cardiomyopathy</subject><subject>Cardiomyopathy, Dilated - diagnosis</subject><subject>Cardiomyopathy, Dilated - etiology</subject><subject>Cardiomyopathy, Dilated - surgery</subject><subject>Catheter Ablation - methods</subject><subject>Congestive heart failure</subject><subject>Coronary artery disease</subject><subject>Embolism</subject><subject>Etiology</subject><subject>Fibrillation</subject><subject>Heart failure</subject><subject>Heart Failure - physiopathology</subject><subject>Heart Failure - surgery</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Patients</subject><subject>Prognosis</subject><subject>Prostate</subject><subject>Risk Factors</subject><subject>Tachycardia</subject><subject>Tachycardia - complications</subject><subject>Treatment Outcome</subject><issn>1382-4147</issn><issn>1573-7322</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kMtKBDEQRYMovn_AhQTcuGlN5WG6lyK-QHAjbkO6u-JEetJjklb8ezOOD3DhKgU591ZxCDkAdgKM6dMETEuoGDQVa3SjKrZGtkFpUWnB-XqZRc0rCVJvkZ2UnhljspFsk2wJKJOWzTZ5vA2vNvlXpHmG0S48JurGSBc2eww50TefZ7QbQzfOfbYh0xnamKmzfpgiUht6anP0dqDOt9EPQwmOYY9sODsk3P96d8nD1eXDxU11d399e3F-V3VCq1ypGpRqdd1J23dKKOuYAgfC4Rm2LXCogWvbcs4FU1L2bevOXMd7qVD3qMUuOV7VLuL4MmHKZu5Th-WIgOOUTAk2XIDgTUGP_qDP4xRDOa5QUNdLgbJQfEV1cUwpojOL6Oc2vhtgZindrKSbIt18SjeshA6_qqd2jv1P5NtyAcQKSOUrPGH83f1P7Qe8lo09</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Wei, Wei</creator><creator>Shehata, Michael</creator><creator>Wang, Xunzhang</creator><creator>Rao, Fang</creator><creator>Zhan, Xianzhan</creator><creator>Guo, Huiming</creator><creator>Fang, Xianhong</creator><creator>Liao, Hongtao</creator><creator>Liu, Jian</creator><creator>Deng, Hai</creator><creator>Liu, Yang</creator><creator>Xue, Yumei</creator><creator>Wu, Shulin</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-9721-3077</orcidid></search><sort><creationdate>20190901</creationdate><title>Invasive therapies for patients with concomitant heart failure and atrial fibrillation</title><author>Wei, Wei ; Shehata, Michael ; Wang, Xunzhang ; Rao, Fang ; Zhan, Xianzhan ; Guo, Huiming ; Fang, Xianhong ; Liao, Hongtao ; Liu, Jian ; Deng, Hai ; Liu, Yang ; Xue, Yumei ; Wu, Shulin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c375t-58155b78c4adc535af051f13fe6ebb1218127ab22230544dbbf6fc2d45e7de73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Animals</topic><topic>Atrial Fibrillation - physiopathology</topic><topic>Atrial Fibrillation - surgery</topic><topic>Cardiac arrhythmia</topic><topic>Cardiology</topic><topic>Cardiomyopathy</topic><topic>Cardiomyopathy, Dilated - diagnosis</topic><topic>Cardiomyopathy, Dilated - etiology</topic><topic>Cardiomyopathy, Dilated - surgery</topic><topic>Catheter Ablation - methods</topic><topic>Congestive heart failure</topic><topic>Coronary artery disease</topic><topic>Embolism</topic><topic>Etiology</topic><topic>Fibrillation</topic><topic>Heart failure</topic><topic>Heart Failure - physiopathology</topic><topic>Heart Failure - surgery</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Patients</topic><topic>Prognosis</topic><topic>Prostate</topic><topic>Risk Factors</topic><topic>Tachycardia</topic><topic>Tachycardia - complications</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wei, Wei</creatorcontrib><creatorcontrib>Shehata, Michael</creatorcontrib><creatorcontrib>Wang, Xunzhang</creatorcontrib><creatorcontrib>Rao, Fang</creatorcontrib><creatorcontrib>Zhan, Xianzhan</creatorcontrib><creatorcontrib>Guo, Huiming</creatorcontrib><creatorcontrib>Fang, Xianhong</creatorcontrib><creatorcontrib>Liao, Hongtao</creatorcontrib><creatorcontrib>Liu, Jian</creatorcontrib><creatorcontrib>Deng, Hai</creatorcontrib><creatorcontrib>Liu, Yang</creatorcontrib><creatorcontrib>Xue, Yumei</creatorcontrib><creatorcontrib>Wu, Shulin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Heart failure reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Wei</au><au>Shehata, Michael</au><au>Wang, Xunzhang</au><au>Rao, Fang</au><au>Zhan, Xianzhan</au><au>Guo, Huiming</au><au>Fang, Xianhong</au><au>Liao, Hongtao</au><au>Liu, Jian</au><au>Deng, Hai</au><au>Liu, Yang</au><au>Xue, Yumei</au><au>Wu, Shulin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Invasive therapies for patients with concomitant heart failure and atrial fibrillation</atitle><jtitle>Heart failure reviews</jtitle><stitle>Heart Fail Rev</stitle><addtitle>Heart Fail Rev</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>24</volume><issue>5</issue><spage>821</spage><epage>829</epage><pages>821-829</pages><issn>1382-4147</issn><eissn>1573-7322</eissn><abstract>Atrial fibrillation (AF) and heart failure (HF) are two clinical entities that can present either separately or concurrently. One entity can lead to the other and vice versa as AF can not only be the underlying etiology of HF but also exacerbate HF due to other cardiac diseases. Besides prevention of cerebral and systemic embolism and elimination of AF-related symptoms, restoration of sinus rhythm for AF patients helps to avoid or reduce HF, irrespective of their underlying heart disease. Successful rates of medical therapy for AF are low in persistent AF, and much lower in long-standing AF, while invasive procedures for AF yield promising results. In this review, the authors evaluate the value of invasive therapies for HF patients complicated with non-valvular AF. We examine this clinical problem by interpreting the relationships between these two entities: the mechanism of tachycardia-induced cardiomyopathy (TIC), past opinions about rhythm control and rate control of AF, discrimination of HF-related AF and AF-induced HF, how to identify the AF patients that could benefit from invasive therapies, and how to select invasive therapies for different AF patients and peri-operative treatments.</abstract><cop>New York</cop><pub>Springer US</pub><pmid>31049749</pmid><doi>10.1007/s10741-019-09795-0</doi><tpages>9</tpages><orcidid>https://orcid.org/0000-0001-9721-3077</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1382-4147 |
| ispartof | Heart failure reviews, 2019-09, Vol.24 (5), p.821-829 |
| issn | 1382-4147 1573-7322 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2229231329 |
| source | MEDLINE; SpringerLink Journals - AutoHoldings |
| subjects | Animals Atrial Fibrillation - physiopathology Atrial Fibrillation - surgery Cardiac arrhythmia Cardiology Cardiomyopathy Cardiomyopathy, Dilated - diagnosis Cardiomyopathy, Dilated - etiology Cardiomyopathy, Dilated - surgery Catheter Ablation - methods Congestive heart failure Coronary artery disease Embolism Etiology Fibrillation Heart failure Heart Failure - physiopathology Heart Failure - surgery Humans Medicine Medicine & Public Health Patients Prognosis Prostate Risk Factors Tachycardia Tachycardia - complications Treatment Outcome |
| title | Invasive therapies for patients with concomitant heart failure and atrial fibrillation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T17%3A21%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Invasive%20therapies%20for%20patients%20with%20concomitant%20heart%20failure%20and%20atrial%20fibrillation&rft.jtitle=Heart%20failure%20reviews&rft.au=Wei,%20Wei&rft.date=2019-09-01&rft.volume=24&rft.issue=5&rft.spage=821&rft.epage=829&rft.pages=821-829&rft.issn=1382-4147&rft.eissn=1573-7322&rft_id=info:doi/10.1007/s10741-019-09795-0&rft_dat=%3Cproquest_cross%3E2218897954%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2218897954&rft_id=info:pmid/31049749&rfr_iscdi=true |